Weekly Digest – 27 May-02 Jun 2023 Weekly Digest – 27 May-02 Jun 2023 May 31, 2023: Repotrectinib (Oral) / NSCLC / BMS: US FDA accepted priority review application The approval is based on subgroup analysis of the Phase 3 […]
Weekly Digest – 27 May-02 Jun 2023 Weekly Digest – 27 May-02 Jun 2023 May 31, 2023: Repotrectinib (Oral) / NSCLC / BMS: US FDA accepted priority review application Precigen announced that the US FDA granted Priority Review and assigned […]
Weekly Digest – 27 May-02 Jun 2023 Weekly Digest – 27 May-02 Jun 2023 May 31, 2023: PRGN-2009 (SC) / Cervical Cancer / Precigen: US FDA approval to initiate Phase 2 trial Precigen announced that the US FDA has approved […]
Weekly Digest – 27 May-02 Jun 2023 Weekly Digest – 27 May-02 Jun 2023 May 31, 2023: ABRYSVO (IM) / Respiratory Syncytial Virus / Pfizer: Approved in the US US FDA has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine) for […]
